Biotech Stock News (MNKD) (SNY) (DVAX) (GSK) (AFFX) (TMO)

Mannkind Corporation (NASDAQ:MNKD) On Tuesday January 5th, 2016 shares of Mannkind fell by more than 48% after it was announced that the collaboration agreement by Sanofi (NYSE:SNY) had been terminated. This agreement was formed way back in 2014 where Sanofi made an upfront payment of $150 million. Sanofi was to take global rights for Afrezza, … Read more

MannKind (MNKD) Stock: We’re Likely To See More Gains From Here!

MannKind Corporation (NASDAQ: MNKD) MannKind Corporation has been dealt a tough hand throughout the beginning of the year. After Afrezza came out, investors were incredibly excited. However, as time went on, impatience got the best of investors who simply couldn’t wait for sales. Soon, MNKD became one of the most heavily shorted stocks in the … Read more

MannKind (MNKD) Stock Presents More Buying Opportunities

MannKind Corporation (NASDAQ: MNKD) In my opinion, MannKind Corporation is one of the most interesting stocks in biotech today. The company has created an incredible product; something that no one has ever seen before. However, pre-launch sales just haven’t been what many expected. Ultimately, this caused the stock to go on a downtrend that still … Read more

MannKind (MNKD) Stock | Why Longs Don’t Care About Declines

MannKind Corporation (NASDAQ: MNKD) If you follow my work here or elsewhere, you know that MannKind is one of my favorite stocks to follow. Aside from the debate revolving around the stock’s ability to grow, I’m intrigued by the fact that this company has come up with a way to deliver insulin to the body … Read more

MannKind (MNKD) Stock Continues Falling | When Will We See Gains

MannKind Corporation (NASDAQ: MNKD) MannKind Corporation has been an incredibly interesting stock to watch recently. After struggling a few months back thanks to a Goldman Sachs downgrade; a research note from Jefferies sent the stock back in bullish mode over the past couple of weeks. However, this week has been a bit of a different … Read more

MannKind (MNKD) Stock | Why I’m Not Worried About Today’s Declines

MannKind Corporation (NASDAQ: MNKD) MannKind has been a very interesting stock to watch over the past few months. First, there was the Goldman Sachs downgrade that sent the stock spiraling down, then there was the Jefferies survey that sent the stock climbing. Now today, the stock is down yet again; but I’m not concerned. As … Read more

MannKind (MNKD) Stock Climbs On Physician Feedback

MannKind Corporation (NASDAQ: MNKD) Following the recent declines that we’ve seen from the stock, MannKind is having a great day in the market today. As with most MNKD price movement, today’s gains can be tied to Afrezza. Essentially, Physicians have provided feedback in a survey from Jefferies; and the feedback was overwhelmingly positive. Today, we’ll … Read more

MannKind (MNKD) Stock | This Will Grow Despite Downgrades

MannKind Corporation (NASDAQ: MNKD) MannKind stock has had a bad run over the last few months. Following a Goldman Sachs downgrade a while back, the stock plummeted; and we’ve seen the same thing this week following a JPMorgan downgrade. However, I’ve got to be honest here…I still see MannKind as a long term gainer despite … Read more